Purpose: AbbVie is expanding its presence in Obesity Therapeutics and is seeking a Principal Scientist to participate in external innovation and diligence efforts to advance the early obesity pipeline. This individual will report to a scientific director of obesity and primarily focus on external innovation activities for obesity assets.
Responsibilities:
- Support external collaborations and licensing opportunities to diversify the pipeline by serving as the Obesity Discovery lead in Search & Evaluation diligence teams. Use personal scientific expertise to advise on scientific merit and drive external innovation.
- Perform literature/intelligence searches to determine scientific and technical approaches for discovery of novel obesity targets emphasizing energy metabolism and energy expenditure leading to weight loss with potential utility in additional indications (neurological disorders, autoimmune disorders).
- Serve as the Obesity Discovery lead in cross functional teams to expand obesity targets into other key therapy areas at AbbVie including but not limited to neuroscience and immunology.
- Coordinate in vitro/in vivo PoC studies for preclinical assets, working with contract research organizations and academic labs to complete key preclinical experiments.
- Apply experience to analyze preclinical PK, in vitro, in vivo data sets for obesity related assets, and to ensure scientific integrity throughout the process.
- Prepare scientific reports and presentations related to pre-clinical obesity assets.
- Design MoA experiments, review protocols, and data sets for late-stage clinical assets.
- Responsible for completing these tasks with minimal supervision.